These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 10394087

  • 1. Regulation of prostaglandin F2alpha by the specific inhibition of secretory type II phospholipase A2: implications for the management of premature labour.
    Munns MJ, King RG, Rice GE.
    Gynecol Obstet Invest; 1999; 48(1):22-7. PubMed ID: 10394087
    [Abstract] [Full Text] [Related]

  • 2. Contribution of type II PLA2 to prostaglandin formation: a study using a type II PLA2 specific inhibitor SB 203347.
    Munns MJ, King RG, Rice GE.
    Prostaglandins Other Lipid Mediat; 1999 Jul; 57(5-6):361-70. PubMed ID: 10480490
    [Abstract] [Full Text] [Related]

  • 3. Reduction of human recombinant type II phospholipase A2 and prostaglandin F2 alpha release by microtubule depolymerizing agents.
    Munns MJ, King RG, Rice GE.
    Clin Exp Pharmacol Physiol; 1999 Mar; 26(3):230-5. PubMed ID: 10081619
    [Abstract] [Full Text] [Related]

  • 4. Antisense oligonucleotide inhibition of type II phospholipase A2 expression, release and activity in vitro.
    Lappas M, Munns MJ, King RG, Rice GE.
    Placenta; 2001 May; 22(5):418-24. PubMed ID: 11373152
    [Abstract] [Full Text] [Related]

  • 5. Secretory type II PLA2 immunoreactivity and PLA2 enzymatic activity in human gestational tissues before, during and after spontaneous-onset labour at term.
    Munns MJ, Farrugia W, King RG, Rice GE.
    Placenta; 1999 Jan; 20(1):21-6. PubMed ID: 9950141
    [Abstract] [Full Text] [Related]

  • 6. Effect of the choline acetyltransferase inhibitor (2-benzoylethyl)-trimethylammonium iodide (BETA) on human placental prostaglandin release and phospholipase A2 activity.
    Chen YS, King RG, Rook TJ, Brennecke SP.
    Placenta; 1993 Jan; 14(6):627-40. PubMed ID: 8153085
    [Abstract] [Full Text] [Related]

  • 7. Release of Type II phospholipase A2 immunoreactivity and phospholipase A2 enzymatic activity from human placenta.
    Farrugia W, Rice GE, Wong MH, Scott KF, Brennecke SP.
    J Endocrinol; 1997 Apr; 153(1):151-7. PubMed ID: 9157179
    [Abstract] [Full Text] [Related]

  • 8. 5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism.
    Berg KA, Maayani S, Clarke WP.
    Mol Pharmacol; 1996 Oct; 50(4):1017-23. PubMed ID: 8863849
    [Abstract] [Full Text] [Related]

  • 9. Recombinant human secretory phospholipase A2: purification and characterization of the enzyme for active site studies.
    Stadel JM, Jones C, Livi GP, Hoyle K, Kurdyla J, Roshak A, McLaughlin MM, Pfarr DA, Comer S, Strickler J.
    J Mol Recognit; 1992 Dec; 5(4):145-53. PubMed ID: 1339483
    [Abstract] [Full Text] [Related]

  • 10. The effect of phospholipase A2 inhibitors on proliferation and apoptosis of murine intestinal cells.
    Longo WE, Grossmann EM, Erickson B, Panesar N, Mazuski JE, Kaminski DL.
    J Surg Res; 1999 Jun 01; 84(1):51-6. PubMed ID: 10334889
    [Abstract] [Full Text] [Related]

  • 11. Relative abundance of human placental phospholipase A2 messenger RNA in late pregnancy.
    Aitken MA, Rice G, Brennecke S.
    Prostaglandins; 1992 Apr 01; 43(4):361-70. PubMed ID: 1376934
    [Abstract] [Full Text] [Related]

  • 12. Gestational tissue phospholipase A2 messenger RNA content and the onset of spontaneous labour in the human.
    Aitken MA, Rice GE, Brennecke SP.
    Reprod Fertil Dev; 1990 Apr 01; 2(5):575-80. PubMed ID: 2075252
    [Abstract] [Full Text] [Related]

  • 13. Late-gestation rat myometrial cells express multiple isoforms of phospholipase A2 that mediate PCB 50-induced release of arachidonic acid with coincident prostaglandin production.
    Brant K, Caruso RL.
    Toxicol Sci; 2005 Nov 01; 88(1):222-30. PubMed ID: 16120751
    [Abstract] [Full Text] [Related]

  • 14. SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock.
    Marshall LA, Hall RH, Winkler JD, Badger A, Bolognese B, Roshak A, Flamberg PL, Sung CM, Chabot-Fletcher M, Adams JL.
    J Pharmacol Exp Ther; 1995 Sep 01; 274(3):1254-62. PubMed ID: 7562496
    [Abstract] [Full Text] [Related]

  • 15. Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.
    Marshall LA, Winkler JD, Griswold DE, Bolognese B, Roshak A, Sung CM, Webb EF, Jacobs R.
    J Pharmacol Exp Ther; 1994 Feb 01; 268(2):709-17. PubMed ID: 8113982
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phospholipase A2 activity in endometrium from early pregnant and non-pregnant ewes.
    Tamby JP, Charpigny G, Reinaud P, Martal J.
    Prostaglandins; 1993 Nov 01; 46(5):407-15. PubMed ID: 8278618
    [Abstract] [Full Text] [Related]

  • 19. Suppression of human synovial fibroblast 85 kDa phospholipase A2 by antisense reduces interleukin-1 beta induced prostaglandin E2.
    Roshak A, Mochan E, Marshall LA.
    J Rheumatol; 1996 Mar 01; 23(3):420-7. PubMed ID: 8832976
    [Abstract] [Full Text] [Related]

  • 20. The role of arachidonic acid in the secretion of the amyloid precursor protein (APP).
    Emmerling MR, Dudley DT, Dyer RD, Carroll RT, Doyle PD, Davis RE.
    Ann N Y Acad Sci; 1996 Jan 17; 777():310-5. PubMed ID: 8624105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.